Advertisement

Merck & Co Company Profile

05:36 EDT 22nd May 2013 | BioPortfolio

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA. We highlight the company's key figures. We explain the history of the name "Merck" and the two companies operating under this name today. We show Merck's visions for the future and guide you through over three hundred years of company history.

Location

Frankfurter Str. 250
Darmstadt
64293
Germany

Contact

Phone: +49 6151 72-0
Fax: +49 6151 72 2000
Email: webmaster@merck.de


News Articles [ 1451 Associated News Articles listed on BioPortfolio]

Merck & Co: Company profile

Return to top 50 pharma list Summary Website: Merck & Co Headquarters: Whitehouse Station, NJ, USA Ticker: MRK (NYSE) SEC: Merck & Co Recent deal news: Merck & Co deal news at Current Part...

Calypso Biotech debuts to develop Merck Serono's IBD R&D

The Merck Serono S.A. division of Merck KGaA (Xetra:MRK) launched Calypso Biotech to develop Merck Serono's preclinical R&D portfolio for gastrointestinal immunological disorders. The newco will conti...

Merck Serono to finance the launch of the EspeRare Foundation

Merck Serono, a division of Merck, Darmstadt, Germany, today announced the launch of the EspeRare Foundation, a nonprofit organization set up by three Merck Serono employees, in the framework of the M...

A history of… Merck KGaA

Did you know that Merck KGaA is the oldest pharmaceutical company in the world? Read our latest ‘a history of’ article to find out more; plus we bust the myths between Merck KGaA and Merck &...

Sixth Merck Serono Spin-off Company to Focus on Gastrointestinal Immunological Disorders

GENEVA, March 4, 2013 /PRNewswire/ -- Newly formed Calypso Biotech will continue research and development of preclinical antibody programs from Merck Serono Merck Serono, a division of Merck, Darm...

Merck Serono's EPP funds EspeRare Foundation, which will reposition rimeporide

Merck Serono, the biotech unit of Germany's Merck KGaA (MRK: DE) has announced the launch of the EspeRare Foundation, a non-profit organization set up by three Merck Serono employees, in the framework...

Merck Serono Ventures nets $77.4 in financing facility from Merck KGaA

Merck announced that it will increase its commitment to its strategic corporate venture capital fund Merck Serono Ventures to € 100 million of financing. Merck Serono Ventures, a subsidiary of the...

Merck Serono Workers To Vote On A Strike

Having already postponed a threatened strike once, Merck Serono employees are planning a job action for next week, depending upon whether the drugmaker accepts at least one of three proposals that wer...

Clinical Trials [ 59 Associated Clinical Trials listed on BioPortfolio]

Study of EMD531444 in Subjects With Stage III Unresectable Non-small Cell Lung Cancer (NSCLC) Following Primary Chemoradiotherapy

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population

Darmstadt, Germany, June 17 2010 - Merck Serono, a division of Merck KGaA, and its U.S. affiliate, EMD Serono, Inc. today announced that they are resuming their Stimuvax® (BLP25 liposome...

Immunogenicity of GSK Bio's HPV Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

HPV infection has been established as a necessary cause of cervical cancer. GSK Biologicals has developed an HPV-16/18 L1 VLP AS04 vaccine which targets the 2 most common oncogenic HPV typ...

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

The purpose of this study is to compare two measles, mumps and rubella conjugate vaccines (manufactured by GSK and Merck and Company ) in terms of the immune response elicited and safety w...

Companies [ 100 Associated Companies listed on BioPortfolio]

Merck & Co

Here you will find an overview of our activities in the core businesses of pharmaceuticals and chemicals. We illustrate the structure of our company. We present the Executive Board of Merck KGaA....

Merck Serono

Merck Serono is the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono...

Merck and Cardiome Pharma Corp.

In April 2009, Cardiome and Merck announced a collaboration and license agreement for the development and commercialization of vernakalant. The agreement provides Merck, Sharp and...

Merck & Co., Inc.

Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, a...

Merck and QIAGEN N.V.

Today's Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vacc...

More Information about "Merck & Co" on BioPortfolio

We have published hundreds of Merck & Co news stories on BioPortfolio along with dozens of Merck & Co Clinical Trials and PubMed Articles about Merck & Co for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Merck & Co Companies in our database. You can also find out about relevant Merck & Co Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement